News Releases

Still, when Murray pressed him, Crawford couldn't say when the FDA may act on Plan B. "Are we talking two weeks? Two years? Twenty years?" she asked him. Initially, she was told there were "issues" the FDA couldn't discuss in public. Then, in private, Murray says she was told that it wasn't the science the agency was still struggling with. It was the "behavior." - (Full Article)

- Seattle Post-Intelligencer - April 13, 2005